Lead UK Investigator:
Daryl Freeman MBChB MRCGP, GP Principal Norfolk; Clinical Director NHS England- Midlands & East(East)
Status: Planned Study, Seeking Funding
The Respiratory Effectiveness Group has developed a risk prediction tool using routinely collected primary care data from the UK to identify patients at increased risk of multiple COPD exacerbations.
This study aims to:
- Develop an equivalent model using administrative insurance claims data to identify patients at increased risk of multiple COPD exacerbations.
- To test the external validity of the UK model by seeking to validate it in a non-UK (claims-based) healthcare setting.
Documents and Publications